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Abstract
Introduction: Studies in the critically ill that evaluate intragastric and post-pyloric delivery of nutrient have yielded
conflicting data. A limitation of these studies is that the influence in the route of feeding on glucose absorption
and glycaemia has not been determined.
Methods: In 68 mechanically ventilated critically ill patients, liquid nutrient (100 ml; 1 kcal/ml containing 3 g of
3-O-Methyl-D-glucopyranose (3-OMG), as a marker of glucose absorption), was infused into either the stomach
(n = 24) or small intestine (n = 44) over six minutes. Blood glucose and serum 3-OMG concentrations were
measured at regular intervals for 240 minutes and the area under the curves (AUCs) calculated for ‘early’ (AUC60)
and ‘overall’ (AUC240) time periods. Data are presented as mean (95% confidence intervals).
Results: Glucose absorption was initially more rapid following post-pyloric, when compared with intragastric,
feeding (3-OMG AUC60: intragastric 7.3 (4.3, 10.2) vs. post-pyloric 12.5 (10.1, 14.8) mmol/l.min; P = 0.008); however,
‘overall’ glucose absorption was similar (AUC240: 49.1 (34.8, 63.5) vs. 56.6 (48.9, 64.3) mmol/l.min; P = 0.31). Post-
pyloric administration of nutrients was also associated with greater increases in blood glucose concentrations in
the ‘early’ period (AUC60: 472 (425, 519) vs. 534 (501, 569) mmol/l.min; P = 0.03), but ‘overall’ glycaemia was also
similar (AUC240: 1,875 (1,674, 2,075) vs. 1,898 (1,755, 2,041) mmol/l.min; P = 0.85).
Conclusions: In the critically ill, glucose absorption was similar whether nutrient was administered via a gastric or
post-pyloric catheter. These data may have implications for the perceived benefit of post-pyloric feeding on
nutritional outcomes and warrant further investigation.
Introduction
Marked malnutrition in the critically ill is associated
with increased morbidity [1,2]. While feeding by the
nasogastric route is preferred, approximately 50% of cri-
tically ill patients fail to meet their caloric needs using
this approach [3,4]. When this occurs, nutrient is fre-
quently delivered directly into the small intestine,
bypassing the stomach [5], in the belief that this will
increase caloric delivery and thereby optimise nutritional
therapy, leading to improved outcomes [6]. However,
data that have evaluated caloric intake during either
intragastric or post-pyloric delivery are inconsistent,
which may relate to the time taken in placing post-pylo-
ric feeding [7-11]. Moreover, the premise that small
intestinal feeding will increase absorption has not been
tested.
We have reported that glucose absorption is markedly
impaired in the critically ill, both following gastric and
small intestinal nutrient administration [12,13]. Glucose
is not absorbed within the stomach, and so absorption
will be limited both by the rate of gastric emptying.
However, we recently observed that even when adminis-
tered directly into the small intestine, glucose absorption
is markedly diminished in critical illness [12]. This latter
finding leads to the hypotheses that factors distal to the
pylorus impair glucose absorption in the critically ill, so
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that post-pyloric nutrient delivery may not increase
nutrient absorption when compared to intragastric
delivery. If post-pyloric feeding does not increase nutri-
ent absorption, it is unlikely to improve clinical
outcomes.
Hyperglycaemia occurs frequently in critically ill
patients and is detrimental to patient outcomes [14].
Furthermore, variability in glycaemia may be just as, or
even more, harmful than elevated mean glucose concen-
trations [15]. Given that the rate of nutrient delivery
from the stomach into the small intestine is a major
determinant of ‘postprandial’ glycaemic excursions in the
critically ill, as well as in health and diabetes [12,16,17], it
is important to determine whether the route of enteral
feeding influences glycaemia in this group.
The primary aim of this study was to evaluate the
effect of the route of enteral feeding (intragastric or
post-pyloric) on glucose absorption in the critically ill,
with the secondary aim of determining effects on
glycaemia.
Materials and methods
We undertook a retrospective analysis of data collected
over a 42-month period (September 2006 to March
2010) in 68 mechanically ventilated, critically ill patients
admitted to a mixed surgical/medical Intensive Care
Unit. These patients were enrolled in studies where glu-
cose absorption was measured after intragastric or post-
pyloric nutrient administration using identical study
protocols [12,13,18].
Subjects
All patients were either receiving, or suitable to receive,
enteral nutrition via intragastric or small intestinal
catheters. Exclusion criteria included: pregnancy; contra-
indication to enteral nutrient or requirement for supple-
mental parenteral nutrition; previous surgery on the
oesophagus, stomach or duodenum; gastrointestinal sur-
gery during that same hospital admission; and a history
of diabetes mellitus. In patients receiving intragastric
feeds insulin was administered if blood glucose concen-
trations were >15 mmol/l [12], whereas during post-
pyloric nutrient delivery insulin was administered as per
unit protocol (>10 mmol/l) [13]. Prokinetic drugs were
withheld for 24 hours prior to study in both groups. All
studies were approved by the Royal Adelaide Hospital
Human Ethics Committee and performed in accordance
with local legal requirements for research conducted on
unconscious patients. Written, informed consent was
obtained from the next of kin.
Protocol
All patients were fasted for at least six hours prior to
commencement of the study [13]. In the intragastric
feeding group a nasogastric feeding tube was inserted
approximately 50 cm below the nares, according to stan-
dard practice guidelines [19]. The intragastric position
of the tube was confirmed using abdominal radiography
and pH testing of aspirates [20]. Small intestinal feeding
catheters were inserted using electromagnetic (n = 32)
or endoscopic techniques (n = 12) [21]. Post-pyloric pla-
cement was confirmed using either abdominal radio-
graph, scintigraphy and/or transmucosal potential
difference [22]. After the position of the feeding tube
was confirmed, the study ‘meal’ was infused via the feed-
ing tube over six minutes. This consisted of 100 mL of
Ensure® (Abbott Laboratories, Bedford, MA, USA; 1
kcal/ml, 64% carbohydrate), mixed with 3 g of 3-O-
Methyl-D-glucopyranose (3-OMG) (Sigma-Aldrich, Cas-
tle Hill, NSW, Australia) dissolved in 5 ml of water. t0
was considered to be the time that the infusion of the
meal was completed. Arterial blood samples were taken
immediately prior to nutrient infusion (t = -6) and at
regular timed intervals (t = 5, 15, 30, 45, 60, 75, 90, 120,
150, 180, 210 and 240 minutes) for the measurement of
3-OMG and blood glucose concentrations.
Measurements
Blood glucose and 3-OMG concentrations
Arterial blood glucose concentrations were determined
using a portable glucose meter (Medisense Precision
QID, Abbott Laboratories). Glucometers were calibrated
prior to each study. Glucose absorption was estimated
using serum 3-OMG concentrations [12,13]. Blood (5
ml) was collected at regular intervals (t = -6 to 240 min-
utes) with serum being separated by centrifugation
(3,200 rpm for 15 minutes at 4°C) and stored at -70°C
for subsequent analysis using High Performance Liquid
Chromatography (HPLC) [13].
Statistical analysis
Data are reported as mean (95% confidence interval),
and presented in the figures as mean (standard deviation
(SD)), unless stated otherwise. Summary data (that is,
t0-60 and t0-240) were generally peaked and, therefore,
areas under the concentration curve (AUC), calculated
using the trapezoidal rule, were used as measures. Data
were assessed for normality and lack of heteroscedalas-
city and these assumptions were met in all cases.
Analyses of ‘early’ and ‘overall’ time points, that is, t60
and t240 minutes were chosen a priori [13]. The rate of
gastric emptying was anticipated to markedly affect
absorption, particularly in the ‘early’ time period
(AUC60), but to have more modest influence on ‘overall’
absorption (AUC240). Total glucose absorption reflects
the extent of substrate absorbed over that time period
as indicated by the area under the serum 3-OMG con-
centration curve (AUC), whereas the rate of absorption
influences the time taken to reach the peak serum
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3-OMG concentrations, while the magnitude of the peak
reflects both of these factors [23]. Independent sample
t-tests were used for analyses and significance was
defined as P <0.05. An independent biostatistician had
access to all data and used SPSS 18 (SPSS Inc., Chicago,
Illinois, United States of America) for analyses.
Relationships were assessed using Pearson Correlation
and evaluated between (i) ‘initial’ glucose absorption
(3-OMG AUC60) and changes in blood glucose concen-
tration at t60; and (ii) peak 3-OMG concentrations
and the maximum increment in blood glucose concen-
tration [13].
Results
Twenty-four patients were recruited in studies where
they were fed via the intragastric route and 44 patients
received post-pyloric feeding. There were no significant
differences in age, weight or body mass index, Acute
Physiology and Chronic Health Evaluation (APACHE) II
scores, serum creatinine or administration of sedative
and analgesic drugs between the two groups (Table 1).
Patients in the small intestinal feeding group were stu-
died later in their admission to the Intensive Care Unit.
Blood glucose concentrations
Fasting blood glucose concentrations were comparable
between the groups (intragastric 7.1 (6.3, 7.9) vs. post-
pyloric 6.9 (6.4, 7.3) mmol/l; P = 0.58) (Figure 1). In
both groups, blood glucose rose after nutrient adminis-
tration (P <0.001). Despite insulin use, post-pyloric
delivery of nutrient was associated with greater glycae-
mic excursions in the ‘early’ period (AUC60: intragastric
472 (425, 519) vs. post-pyloric 534 (501, 569) mmol/l.
min; P = 0.03), and there was a trend for an increase in
the peak excursion (9.2 (8.4, 10.1) vs. 10.2 (9.5, 10.8)
mmol/l; P = 0.09). Blood glucose concentrations at t60
(8.2 (7.3, 9.2) vs. 9.0 (8.3, 9.8) mmol/l; P = 0.19) and
‘overall’ glycaemia (AUC240: 1,875 (1,674, 2,075) vs.
1,898 (1,755, 2,041) mmol/l.min; P = 0.85) were similar
in the two groups.
Serum 3-OMG concentrations (glucose absorption)
In all patients, 3-OMG concentrations increased after
both infusions, and at study end (t240), remained greater
than zero in all patients (Figure 2). However, adminis-
tration of nutrient directly into the small intestine
resulted in increased glucose absorption during the
‘early’ period when compared with intragastric feeding
(AUC60 intragastric 7.3 (4.3, 10.2) vs. post-pyloric 12.5
(10.1, 14.8) mmol/l.min; P = 0.008). Small intestinal
feeding was also associated with a reduced time to peak
(Time to Peak 3-OMG: 132 (100, 164) vs. 78 (61, 95)
minutes; P = 0.001), although there was no difference in
3-OMG peak concentrations in the two groups (0.29
(0.20 to 0.39) vs. 0.37 (0.31 to 0.43) mmol/l; P = 0.13).
‘Overall’ glucose absorption (AUC240) was similar
Table 1 Demographic data
Feeding site Intragastric Post-pyloric
Subjects (n) 24 44
Age (years) 52 (45, 60) 52 (47, 57)
Sex (n) Male 19 (79%) 36 (82%)
Body Mass Index (kg/m2) 26 (23, 28) 27 (25, 29)
APACHE II Score:
Admission † 21 (11 to 38) 20 (7 to 40)
Day of Study† 16 (6 to 27) 16 (4 to 30)
Admission diagnosis
Trauma 6 (25%) 13 (30%)
Pneumonia/Respiratory 5 (21%) 13 (30%)
Sepsis (Other source) 4 (17%) 5 (12%)
Neurosurgical/Neurology 4 (17%) 3 (7%)
Burn injury 2 (8%) 3 (7%) 3 (7%)
Cardiac surgery/ 2 (8%)
Cardiology 4 (9%)
Pancreatitis 1 (4%)
Time from admission to study day (days) † 4 (1 to 10) 8 (1 to 38)*
Insulin administered during study (number (%)) 0 (0%) 20 (45%) **
Sedative and analgesic drugs administration1 (number (%)) 16 (67%) 21 (48%)
Serum creatinine (μmol/l) 68 (19 to 248) 66 (29 to 357)
1 Sedative and analgesic drug administration was defined as fentanyl or propofol on study day. (APACHE II, Acute Physiology and Chronic Health Evaluation II)
Data are mean (95% confidence intervals) or † median (range). * denotes P = 0.004 **P <0.001
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Figure 1 Blood glucose concentrations following administration of nutrient via intragastric and post-pyloric routes. For the initial 60
minutes after the infusion, glycaemic excursions were greater following post-pyloric administration of nutrient (*P = 0.03), but, over the entire
240 minutes, glucose concentrations were comparable between the two groups (P = 0.85). Data are mean ± SD.
















Figure 2 Glucose (3-OMG) absorption following administration of nutrient via intragastric and post-pyloric routes. ‘Early’ glucose
absorption was increased following post-pyloric delivery (* P = 0.008). While ‘overall’ glucose absorption was similar between intragastric and
post-pyloric feeding route (P = 0.31). Data are mean ± SD.
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between intragastric and post-pyloric feeding route
(AUC240 49.1 (34.8, 63.5) vs. 56.6 (48.9, 64.3) mmol/l.
min; P = 0.31).
Relationships between 3-OMG and blood glucose
concentrations
In the whole group there was a relationship between rise
in glycaemia and glucose absorption (3-OMG AUC60
and Δ blood glucose concentration at t60 when com-
pared to fasting glucose, r = 0.50; P <0.001, and serum
3-OMG and blood glucose concentrations at t60 r =
0.41; P <0.001). There was also an association between
the maximum increment in blood glucose and the rate
of glucose absorption (for example, 3-OMG peak and
Δmax in blood glucose, r = 0.37; P = 0.02).
Discussion
The key observation in this study is that small intestinal
delivery of nutrient, when compared to intragastric
administration, appeared to have little effect on ‘overall’
glucose absorption over 240 minutes.
To our knowledge, this study is the first to compare
the effect of route of enteral feeding (gastric versus
small intestinal) on glucose absorption in the critically
ill. Previous studies have quantified glucose absorption
following gastric and small intestinal administration
independently [12,13]. Glucose absorption following
intragastric administration is known to be markedly
impaired in critical illness compared to ‘health’, and the
slower initial rate of absorption is, at least in part, attri-
butable to delayed gastric emptying [12]. However, glu-
cose absorption following small intestinal administration
is also attenuated in the critically ill, indicating that
small intestinal factors are pivotal to the malabsorption
of glucose in this group [13]. While the underlying
mechanisms are as yet unknown, several ‘small intest-
inal’ abnormalities that have the capacity to reduce glu-
cose absorption have been observed in the critically ill,
including abnormal small intestinal motility [6], and
mucosal abnormalities, such as decreased villus height
and crypt depth [24]. The effects of critical illness on
the microstructure of the small intestine in humans are
unknown, but in an animal model of critical illness a
reduction in expression of the duodenal sodium-glucose
co-transporter was evident suggesting defective glucose
transportation by enterocytes [25].
Some authorities recommend that enteral nutrition be
preferentially delivered via small intestinal feeding cathe-
ters [26]. The proposed benefits of this approach are an
increase in nutrient delivery and a reduction in nosoco-
mial pneumonia [9,27,28]. However, our study suggests
that glucose absorption, particularly after the ‘initial’
period, may be similar, regardless of the route of deliv-
ery. Because of this observation the perceived nutritional
benefits of post-pyloric feeding are open to reevaluation.
While small intestinal feeding may potentially reduce
the risk of nosocomial pneumonia by a reduction in gas-
tric volumes and, thereby, gastro-oesophageal reflux and
pulmonary aspiration [27], the latter outcomes were not
assessed in our study. However, the relationship
between gastroesophageal reflux and slow gastric empty-
ing has not been established in the critically ill [29].
Marked hyperglycemia leads to adverse outcomes in
the critically ill [30]. In addition, glycaemic variability
(or wider swings in glycaemia) appears to be an inde-
pendent predictor of mortality [15]. The rate of gastric
emptying influences, and is influenced by, blood glucose
concentrations in ‘health’, type-2 diabetes and critical ill-
ness [12,17,31]. Our study suggests that delivery of glu-
cose directly into the small intestine, which bypasses the
regulatory effect of gastric emptying, has the potential
to exacerbate glycaemic excursions. It is, therefore, plau-
sible that any potential benefits from post-pyloric nutri-
tion may be negated by inferior glycaemic control.
Future studies that evaluate the effects of route of feed-
ing (that is, intragastric vs. post-pyloric) should consider
the potential impact on glycaemia.
There are limitations to this study that should be
recognised. The route of feeding was not randomised,
but, despite this, the groups appeared to be well
matched according to most parameters, including illness
severity. The post-pyloric feeding cohort were studied
later in their ICU stay, and abnormalities within the gas-
trointestinal tract have been reported to improve during
a patient’s admission [32]. This would, if anything, have
favoured improved glucose absorption in this group,
which was not observed. Insulin protocols varied due to
the retrospective nature of the study. The insulin regi-
men was more intensive in the patients fed by the post-
pyloric route with insulin administered at lower blood
glucose concentrations. Possibly due to both a more
intensive insulin regimen and/or higher blood glucose
concentrations, more patients in the post-pyloric cohort
received insulin, but given that insulin per se, may
increase small intestinal glucose absorption [33], the
similar glucose absorption observed in the two routes of
feeding is even more remarkable. It should be recog-
nised that it cannot be assumed that the increase in gly-
caemic excursions was exclusively due to post-pyloric
delivery of nutrient, as there may have been other fac-
tors that influenced glucose metabolism (for example,
counter-regulatory hormones including glucagon) that
were not measured.
Due to the retrospective design, our study may have
been underpowered. Sixty-eight subjects, however,
represents a substantial cohort, and this sample was suf-
ficient to show a mean difference in AUC240 3-OMG
concentrations (glucose absorption) of 4.0 mmol/l.min,
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with b and a errors of 0.8 and 0.05 respectively. Differ-
ences less than this are unlikely to be of clinical signifi-
cance. Another potential limitation is that the meal was
administered as a bolus, which may have implications
for the interpretation of our data. In principle, glucose
absorption in the post-pyloric group may have been
underestimated, because delivery of nutrient into the
small intestine at rates that are above those of ‘normal’
gastric emptying could, conceivably, lead to suboptimal
absorption. On the other hand, slow gastric emptying in
the intragastric feeding cohort would have introduced a
bias towards reduced absorption in that group, rather
than showing comparable effects to post-pyloric feeding.
It is also possible that delivery of a bolus into the small
intestine exacerbated glycaemic excursions, because the
rate of entry of glucose into the small intestine is a
major determinant of glycaemia in health, type-2 dia-
betes and critical illness [12,17,31].
Despite these limitations, our observations highlight the
need to undertake prospective studies to confirm and/or
further explore our hypothesis-generating results. In parti-
cular, a prospective randomised study evaluating intragas-
tric versus small intestinal feeding at infusions rates that
better reflect routine practice would be desirable.
Conclusions
Small intestinal administration of nutrient increases the
initial, but does not appear to affect the ‘overall’, rate of
glucose absorption, when compared to gastric adminis-
tration. However, more rapid initial glucose absorption
during post-pyloric feeding has the potential to affect
glycaemia adversely. Further studies examining the
impact of the route of feeding on nutrient absorption
and nutritional outcomes are desirable.
Key messages
• When compared to intragastric administration,
post-pyloric delivery of nutrient did not increase the
glucose absorption over a four-hour period.
• The perceived benefit of post-pyloric feeding on
nutritional outcomes warrants further evaluation.
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